David Zaccardelli

2021 - Verona Pharma plc

In 2021, David Zaccardelli earned a total compensation of $1.1M as President and Chief Executive Officer at Verona Pharma plc, a 94% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$328,313
Salary$272,500
Stock Awards$496,035
Other$26,456
Total$1,123,304

Zaccardelli received $496K in stock awards, accounting for 44% of the total pay in 2021.

Zaccardelli also received $328.3K in non-equity incentive plan, $272.5K in salary and $26.5K in other compensation.

Rankings

In 2021, David Zaccardelli's compensation ranked 8,386th out of 12,412 executives tracked by ExecPay. In other words, Zaccardelli earned more than 32.4% of executives.

ClassificationRankingPercentile
All
8,386
out of 12,412
32nd
Division
Manufacturing
3,714
out of 5,498
32nd
Major group
Chemicals And Allied Products
1,650
out of 2,374
31st
Industry group
Drugs
1,468
out of 2,095
30th
Industry
Pharmaceutical Preparations
1,092
out of 1,542
29th
Source: SEC filing on March 22, 2022.

Zaccardelli's colleagues

We found three more compensation records of executives who worked with David Zaccardelli at Verona Pharma plc in 2021.

2021

Mark Hahn

Verona Pharma plc

Chief Financial Officer

2021

Mark Hahn

Verona Pharma plc

Chief Financial Officer

2021

Kathleen Rickard

Verona Pharma plc

Chief Medical Officer

News

You may also like